middle.news
BlinkLab Secures A$17.5M to Accelerate Autism and ADHD Diagnostic Launches
9:36am on Thursday 16th of April, 2026 AEST
•
Healthcare
Read Story
BlinkLab Secures A$17.5M to Accelerate Autism and ADHD Diagnostic Launches
9:36am on Thursday 16th of April, 2026 AEST
Key Points
Oversubscribed A$17.5 million placement at A$0.65 per share
Funds to complete FDA 510(k) autism trial and advance European approvals
Launch and initiate FDA trial for ADHD diagnostic platform
Board and management invested A$200K, subject to shareholder approval
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE